67624-25-3 Usage
Uses
Used in Pharmaceutical Industry:
2H-Benzimidazole-2-thione,1,3-dihydro-1-propyl-(9CI) is used as a potential pharmaceutical agent for its possible antimicrobial, antiviral, and antitumor properties. 2H-Benzimidazole-2-thione,1,3-dihydro-1-propyl-(9CI)'s unique structure and functional groups may contribute to its therapeutic effects, making it a candidate for further research and development in the medical field.
Further research and testing are necessary to fully understand the potential applications and benefits of 2H-Benzimidazole-2-thione,1,3-dihydro-1-propyl-(9CI) in various industries, particularly in the pharmaceutical sector.
Check Digit Verification of cas no
The CAS Registry Mumber 67624-25-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,6,2 and 4 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 67624-25:
(7*6)+(6*7)+(5*6)+(4*2)+(3*4)+(2*2)+(1*5)=143
143 % 10 = 3
So 67624-25-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2S/c1-2-7-12-9-6-4-3-5-8(9)11-10(12)13/h3-6H,2,7H2,1H3,(H,11,13)
67624-25-3Relevant academic research and scientific papers
Synthesis of N-substituted benzimidazole-2-thiones
Doerge,Cooray
, p. 1789 - 1795 (2007/10/02)
General methods were developed for N-substitution of benzimidazoline-2-thione with alkyl, alkenyl, alkynyl and acyl groups using S-tritylation as a protecting reaction.
A Facile One Pot Synthesis of 1-Alkylbenzimidazoline-2-thiones
Lee, Tae Ryong,Kim, Kyongtae
, p. 747 - 751 (2007/10/02)
Reactions of benzimidazoline-2-thione with alkyl halides in the presence of sodium naphthalenide in tetrahydrofuran at room temperature under a nitrogen atmosphere afforded 1-alkyl-2-alkylthiobenzimidazoles in excellent yields, which underwent a bond cleavage between S and C of alkyl group to give excellent yields of 1-alkylbenzimidazoline-2-thiones by the treatment with an additional amount of sodium naphthalenide.
